Electra Therapeutics, Inc
Last verified 2026-05-20. JSON
| Total raised | $134.2M |
|---|---|
| Latest round | Funding round, $134.2M, 2025-10-15 |
| Founded | 2018 |
| Headquarters | South San Francisco, CA |
| Industry | biotechnology |
| Stage | unknown |
| Website | electra-therapeutics.com |
Electra Therapeutics develops antibody therapies that target Signal Regulatory Proteins to treat immunological diseases and cancer. It serves patients with inflammatory conditions such as sHLH that lack treatment options, led by ELA026. Its SIRP-targeting approach depletes pathological immune cells while sparing healthy ones.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-10-15 | Funding round | $134.2M | undisclosed |
Detected tech stack
Cloudflare, reCAPTCHA, Google Tag Manager, jQuery Migrate 3.4.1, Elementor 4.0.7, Cloudflare Bot Management, CookieYes 3.4.0, WordPress, WP Engine, Python, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $134.2M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $134.2M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | electra-therapeutics.com, read 2026-05-20 |
| Description | self-reported | electra-therapeutics.com, read 2026-05-20 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $134.2M, 2025-10-15 → Funding round, $134.2M, 2025-10-15, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $134.2M, 2025-10-15 → Funding round, $134.2M, 2025-10-15 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes